Today: 28 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

Coca-Cola stock price slips despite Wells Fargo target hike as KO earnings loom

Coca-Cola shares fell 1.2% to $78.08 Monday as consumer staples lagged a tech-led rebound. Wells Fargo raised its price target on Coca-Cola to $87, maintaining an “overweight” rating ahead of Tuesday’s earnings. Investors await signals on demand and pricing, with options traders bracing for a 3% swing. Broader markets focused on upcoming U.S. jobs and inflation data.
9 February 2026
··
Teradyne stock rises as chip-test names rebound; traders scan downgrades and U.S. data

Teradyne stock rises as chip-test names rebound; traders scan downgrades and U.S. data

Teradyne shares climbed 3.3% to $309.95 in Monday afternoon trading, following a volatile session and a 60% gain year-to-date. President Capital Management downgraded the stock to neutral but raised its price target to $308. Investors await U.S. jobs and inflation data later this week, which could affect rate-cut expectations. Teradyne’s next dividend record date is February 13.
9 February 2026
··
Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp shares jumped 7.2% to $244.13 Monday after Bank of America raised its price target to $250, maintaining a Neutral rating. The move followed volatile trading after earnings and comes as investors focus on AI-driven optical demand and upcoming U.S. inflation data. Other optical stocks also gained. Coherent forecast third-quarter revenue of $1.70–$1.84 billion and non-GAAP EPS of $1.28–$1.48.
9 February 2026
····
Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital stock jumps nearly 10% as AI data-center trade rebounds; what’s next for APLD

Applied Digital shares jumped 9.6% to $38.32 Monday afternoon, swinging between $33.48 and $39.33 on heavy volume. No new company news was posted. About a third of the float was sold short as of mid-January, heightening volatility. Traders are eyeing U.S. payrolls and CPI data later this week for further market direction.
9 February 2026
···
Philip Morris (PM) stock price slips today despite fresh target hikes as Zyn battle stays in view

Philip Morris (PM) stock price slips today despite fresh target hikes as Zyn battle stays in view

Philip Morris International shares fell 1.4% to $180.17 in Monday afternoon trading after a new debt shelf filing and recent earnings guidance. Investors focused on competition in nicotine pouches and upcoming U.S. economic data. The stock traded between $179.85 and $182.54, about 1.6% below its 52-week high. Several analysts raised their price targets following the company’s updated 2026 outlook.
9 February 2026
·
Arrowhead Pharmaceuticals stock swings as S&P MidCap 400 move lands and Goldman flags 2026 catalysts (ARWR)

Arrowhead Pharmaceuticals stock swings as S&P MidCap 400 move lands and Goldman flags 2026 catalysts (ARWR)

Arrowhead Pharmaceuticals shares fell 0.7% to $64.10 in afternoon trading Monday after moving from the S&P SmallCap 600 to the S&P MidCap 400. The stock saw heavy volume and a wide intraday range. Goldman Sachs maintained a Neutral rating and $85 target, citing key 2026 pipeline data and competition from Ionis Pharmaceuticals. Arrowhead recently reported Q1 revenue of $264 million and 22 cents EPS.
9 February 2026
··
Microchip stock drops on $600 million convertible-notes plan — what investors watch next

Microchip stock drops on $600 million convertible-notes plan — what investors watch next

Microchip Technology shares fell about 2% to $74.52 after the company announced a $600 million convertible notes offering. Proceeds will fund capped-call hedges and repay commercial paper borrowings. The notes mature in 2030 and will be sold privately to institutional buyers. Traders are watching for final pricing and hedging flows that could move the stock.
9 February 2026
··
Merck stock drops nearly 4%: why MRK is lagging the market today

Merck stock drops nearly 4%: why MRK is lagging the market today

Merck shares fell 3.9% to $117.16 Monday, underperforming the broader market as investors weighed patent risks and 2026 earnings guidance. Amgen, Pfizer, and AbbVie also declined. Merck last week projected 2026 sales of up to $67 billion and warned of a $2.5 billion hit from generic competition and weaker COVID-19 drug sales. The Dow lagged as Merck and Amgen dragged on the index.
9 February 2026
··
Intuit stock drops in afternoon trade as TD Cowen cuts target and AI jitters linger

Intuit stock drops in afternoon trade as TD Cowen cuts target and AI jitters linger

Intuit shares fell 1.3% to $438.01 Monday, underperforming a 2.4% gain in the broader software sector. TD Cowen cut its price target to $658, citing AI concerns, while Jefferies maintained an $850 target, calling AI fears “too harsh.” The stock traded between $431.53 and $447.00. Investors are watching for Intuit’s quarterly results on Feb. 26.
9 February 2026
··
Palo Alto Networks stock jumps as Nasdaq sets a close date for the CyberArk deal

Palo Alto Networks stock jumps as Nasdaq sets a close date for the CyberArk deal

Palo Alto Networks shares rose 3.4% to $164.81 Monday after Nasdaq set a tentative Feb. 11 closing date for its $25 billion CyberArk merger. CyberArk shares gained 4% to $407.38, with trading set to halt after-hours Feb. 10. The deal gives CyberArk holders $45 cash and 2.2005 Palo Alto shares per share. Investors await Palo Alto’s quarterly results on Feb. 17 for updates on integration and demand.
9 February 2026
····
Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher shares rose 0.1% to $543.48 Monday after the company filed for a four-part senior notes offering to help fund its planned Clario acquisition. The preliminary prospectus left key terms blank and showed $39.38 billion in consolidated debt as of Dec. 31, 2025. S&P rated the proposed debt ‘A-’. Executive Gianluca Pettiti filed to sell 400 shares valued at $216,480.
9 February 2026
·
AST SpaceMobile stock (ASTS) whipsaws in New York trade as the next satellite milestone nears

AST SpaceMobile stock (ASTS) whipsaws in New York trade as the next satellite milestone nears

AST SpaceMobile shares fell 0.5% to $101.28 by 2:13 p.m. EST after swinging between $98.95 and $108.25 in volatile trading. The move came as broader U.S. markets rose and investors awaited updates on the BlueBird 7 satellite launch, now scheduled for no earlier than late February. Blue Origin will handle the launch from Cape Canaveral. The company still needs more regulatory approvals and capital for its planned 2026 rollout.
9 February 2026
·
1 … 99 100 101 102 103 … 725

Stock Market Today

  • Telix Pharmaceuticals Update Drives Shift in ASX Healthcare Sector
    March 28, 2026, 5:20 PM EDT. Telix Pharmaceuticals triggered a notable shift in the ASX healthcare sector following its recent corporate update. Investor attention focused on Telix's pipeline progress and strategic developments, influencing sector momentum. The Australian Securities Exchange (ASX) saw healthcare shares respond, reflecting changing investor sentiment. Market participants weighed Telix's clinical and commercial prospects, fueling renewed interest amid broader healthcare stock movements. This activity underlines Telix's role as a catalyst within the sector, impacting trading dynamics and signaling possible future investment trends in Australian healthcare equities.
Go toTop